GoalVest Advisory’s Hologic HOLX Stock Holding History

GoalVest Advisory’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	–	–	403
2022 Q1	$0	Buy	+3	New	+$216	﹤0.01%	431

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

GoalVest Advisory's HOLX Position: Q2 2022 in Review

GoalVest Advisory sold out of Hologic (HOLX) in Q2 2022, closing a stake of 3 shares.

GoalVest Advisory first reported a position in HOLX in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

GoalVest Advisory reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
GoalVest Advisory sold 3 Hologic shares in Q2 2022.
GoalVest Advisory first reported a position in Hologic in Q1 2022 and held it in 1 quarter.
GoalVest Advisory's Hologic position peaked at $0 in Q1 2022.
695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on GoalVest Advisory's 13F filing for Q2 2022, filed 6 Jul 2022.